• Policy
• There is a need to apply the HPV vaccine NIP Men Under 17
• by Lee, Jeong-Hwan Aug 31, 2021 06:13am

• Company
• A lawsuit is scheduled to be filed against the price system
• by Nho, Byung Chul Aug 30, 2021 05:55am

• Company
• Entry of generics halt Nexavar’s sole lead in liver cancer
• by Kim, Jin-Gu Aug 30, 2021 05:55am

• Policy
• Korean pharmas are pursuing various SGLT-2 combos
• by Lee, Tak-Sun Aug 30, 2021 05:55am

• Policy
• The patent for Breast Cancer Therapy Affinitor has been clos
• by Lee, Tak-Sun Aug 30, 2021 05:55am

• Company
• Cosentyx begins competition in the market
• by Aug 30, 2021 05:54am

• Policy
• Regulation of COVID-19 vaccines is imminent
• by Lee, Jeong-Hwan Aug 27, 2021 05:59am

• Opinion
• [Reporter’s View]Reimbursement of antidiabetic combos
• by Eo, Yun-Ho Aug 27, 2021 05:59am

• Company
• Shingles vaccine market overwhelmed by COVID-19… drops 60%
• by An, Kyung-Jin Aug 27, 2021 05:59am

• Policy
• RSA refund should be differentiated by income
• by Kim, Jung-Ju Aug 27, 2021 05:59am